Gilead Sciences, Inc.
GILD
$148.95
$5.183.60%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.18B | 3.05B | 1.96B | 1.32B | 1.78B |
| Total Depreciation and Amortization | 687.00M | 686.00M | 691.00M | 696.00M | 693.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.06B | 667.00M | 190.00M | 779.00M | 16.00M |
| Change in Net Operating Assets | -604.00M | -297.00M | -2.01B | -1.03B | 483.00M |
| Cash from Operations | 3.33B | 4.11B | 827.00M | 1.76B | 2.98B |
| Capital Expenditure | -205.00M | -147.00M | -107.00M | -104.00M | -147.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -609.00M | -167.00M | -21.00M | -273.00M | -75.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.02B | -113.00M | -1.99B | -38.00M | -3.00M |
| Cash from Investing | -1.84B | -427.00M | -2.12B | -415.00M | -225.00M |
| Total Debt Issued | -- | -- | -- | -- | 3.46B |
| Total Debt Repaid | -8.00M | -9.00M | -9.00M | -1.76B | -7.00M |
| Issuance of Common Stock | 32.00M | 97.00M | 27.00M | 252.00M | 173.00M |
| Repurchase of Common Stock | -230.00M | -435.00M | -527.00M | -730.00M | -350.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -994.00M | -1.01B | -994.00M | -1.01B | -973.00M |
| Other Financing Activities | -63.00M | -137.00M | -64.00M | -176.00M | -47.00M |
| Cash from Financing | -1.26B | -1.49B | -1.57B | -3.43B | 2.26B |
| Foreign Exchange rate Adjustments | 5.00M | -5.00M | 73.00M | 19.00M | -55.00M |
| Miscellaneous Cash Flow Adjustments | -- | -1.00M | 1.00M | -- | -- |
| Net Change in Cash | 234.00M | 2.19B | -2.78B | -2.07B | 4.96B |